Real-life experiences with galcanezumab and predictors for treatment response in Turkey

The complexity of clinical practice extends far beyond the controlled settings of trials, and there is a need for real-world studies aimed at identifying which patients will respond to anti-CGRP monoclonal ant...

Source: BMC Neurology - November 23, 2023 Category: Neurology Authors: P ınar Yalinay Dikmen, Betül Baykan, Derya Uludüz, Aynur Özge, Elif Ilgaz Aydınlar, Burcu Polat, Necdet Karlı, Nermin Tepe, Neşe Çelebisoy, Hayal Ergin Toktaş, Buket Niflioğlu, Rahşan Karacı, Füsun Mayda Domaç, Ezgi Uludüz, Tuba Erdogan Soy Tags: Research Source Type: research